Gingival Crevicular Fluid Biomarkers and Healing After Root Canal Treatment in Asymptomatic Apica… (NCT07468643) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Gingival Crevicular Fluid Biomarkers and Healing After Root Canal Treatment in Asymptomatic Apical Periodontitis
Egypt60 participantsStarted 2025-05-02
Plain-language summary
This prospective observational cohort study will evaluate whether changes in gingival crevicular fluid osteoprotegerin (OPG) , RANKL/OPG ratio ,IL10,IL8and CxCL10 after primary nonsurgical root canal treatment are associated with 12-month radiographic healing in teeth with asymptomatic apical periodontitis. Participants will undergo standardized treatment and follow-up with serial GCF sampling and standardized digital periapical radiography.
Who can participate
Age range18 Years – 40 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
Adults 18 -40 years .
Presence of one permanent tooth diagnosed with asymptomatic apical periodontitis.
Diagnosis confirmed by pulp necrosis or non-vital pulp and presence of a periapical radiolucency on digital periapical radiograph.
Tooth indicated for primary nonsurgical root canal treatment.
Tooth must be restorable and periodontally healthy.
Periapical lesion detectable radiographically and suitable for follow-up evaluation.
Participant able and willing to provide written informed consent.
Participant willing to attend follow-up visits during the study period.
Exclusion Criteria
Participants will be excluded if any of the following conditions are present:
Teeth previously treated with root canal treatment (retreatment cases).
Teeth with acute apical abscess, swelling, or sinus tract.
Teeth with combined endodontic-periodontal lesions.
Periodontal pockets \>3 mm or evidence of active periodontal disease around the study tooth.
Teeth with vertical root fracture, root perforation, or severe root resorption.
Teeth with hopeless restorative or periodontal prognosis.
Patients with systemic diseases that may affect healing (e.g., uncontrolled diabetes, immunosuppression).
Pregnant or breastfeeding women.
Patients currently taking systemic antibiotics, corticosteroids, or anti-inflammatory medications within the last 2 weeks.
Current smokers or tobacco users.
Inability to attend scheduled follow-up visits.